Anika Therapeutics | ANIK - 贸易债权人





贸易债权人 更改 日
Abbott USD 4.24B 117M 2025-12
Agenus USD 82.99M 2.3M 2025-12
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Anika Therapeutics USD 6.34M 298K 2026-03
Arrowhead Research USD 32.94M 15.26M 2025-12
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Heron Therapeutics USD 8.99M 3.02M 2025-12
Insmed USD 79.91M 316K 2025-12
Integra LifeSciences USD 95.73M 3.42M 2025-12
Intrexon USD 4.85M 3.12M 2024-06
J&J USD 10.46B 1.53B 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Ligand Pharmaceuticals USD 3.24M 24.52M 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
Merit Medical Systems USD 67.85M 7.3M 2026-03
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.71B 219M 2026-03
Smith & Nephew USD 1.19B 73M 2025-12
Stryker USD 1.8B 301M 2025-12
Surmodics USD 5.93M 3.14M 2025-06
Veracyte USD 4.59M 916K 2025-12
Xencor USD 10.83M 1.75M 2025-12
Zimmer Biomet Holdings USD 361.2M 58.2M 2026-03